- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Wall Street Zen Upgrades McKesson Stock to Buy Rating
Analysts cite strong financial performance and growth potential for the healthcare distribution company.
Mar. 22, 2026 at 5:09am
Got story updates? Submit your updates here. ›
Wall Street Zen, an equity research firm, has upgraded its rating on McKesson (NYSE: MCK) stock from "hold" to "buy". The upgrade comes after the company reported strong financial results, with revenue and earnings exceeding analyst expectations. McKesson is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and technology solutions.
Why it matters
The upgrade from Wall Street Zen is a positive sign for McKesson, as it indicates the company's business is performing well and has potential for further growth. As one of the largest healthcare distributors in the U.S., McKesson's financial health and outlook are closely watched by investors and analysts.
The details
In its research report, Wall Street Zen cited McKesson's solid financial performance, including a 11.4% year-over-year increase in revenue and strong earnings growth. The analysts also pointed to the company's strategic initiatives, such as investments in specialty pharmacy services and medical-surgical supply distribution, as drivers of future growth.
- McKesson reported its latest quarterly results on Wednesday, February 4, 2026.
- Wall Street Zen issued its research report and rating upgrade on Sunday, March 22, 2026.
The players
Wall Street Zen
An equity research firm that provides analysis and ratings on publicly traded companies.
McKesson
A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products, and technology solutions.
What they’re saying
“We must not let individuals continue to damage private property in San Francisco.”
— Robert Jenkins, San Francisco resident
“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”
— Gordon Edgar, grocery employee
The takeaway
The upgrade of McKesson's stock rating by Wall Street Zen is a positive sign for the company, reflecting its strong financial performance and growth potential in the healthcare distribution and services industry. This development underscores McKesson's position as a leading player in the sector and its ability to navigate the evolving healthcare landscape.


